Aslan Pharmaceuticals Financials

Aslan Pharmaceuticals Stock Summary

Aslan Pharmaceuticals competes with Monte Rosa, NewAmsterdam Pharma, Inventiva, Cullinan Oncology, and Compass Therapeutics. ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company was founded in 2010 and is headquartered in Singapore. Aslan Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 27 people.

Aslan Pharmaceuticals Key Financial Ratios

Aslan Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Aslan Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Aslan Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aslan Pharmaceuticals competition to find correlations between indicators driving Aslan Pharmaceuticals's intrinsic value. More Info.Aslan Pharmaceuticals is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aslan Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Aslan Pharmaceuticals Market Pulse

Along with financial statement analysis, the daily predictive indicators of Aslan Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aslan Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aslan Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Aslan Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aslan Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

If you are still planning to invest in Aslan Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aslan Pharmaceuticals' history and understand the potential risks before investing.